Loading grant details…
Active
NON-SBIR/STTR RPGS
NIH (US)
Targeted EGFR for basal subtype pancreatic cancer
$6.4M
USD
| Funder | NATIONAL CANCER INSTITUTE |
|---|---|
| Recipient Organization | University of North Carolina Chapel Hill |
| Country | United States |
| Start Date | Feb 01, 2024 |
| End Date | Jan 31, 2029 |
| Duration | 1,826 days |
| Number of Grantees | 2 |
| Roles | Co-Investigator; Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 10826126 |
Grant Description
Abstract We and others have shown that basal tumors, which comprise
All Grantees
University of North Carolina Chapel Hill
Advertisement
Advertisement
Interested in applying for this grant?
Complete our application form to express your interest and we'll guide you through the process.
Apply for This GrantQuick Summary
Start Year
2024
End Year
2029
Grantees
2
Related Grants
AIDS Clinical Trials Group for Research on Therapeutics for...
NATIONAL INSTITUTE OF ALLERGY AND INFECT...
$762.2K USD
Leadership and Operations Center (LOC), AIDS Clinical Trials...
NATIONAL INSTITUTE OF ALLERGY AND INFECT...
$715K USD
Development of outpatient antiviral cocktails against SARS-C...
NATIONAL INSTITUTE OF ALLERGY AND INFECT...
$690.6K USD
Advertisement
